Abstract
We have previously demonstrated both a structural and a functional regeneration of the cardiac lesion in patients with acute myocardial infarction (AMI) after direct intra-cardiac delivery of autologous peripheral blood-CD34+ stem cells collected after mobilization by G-CSF. The whole procedure was heavy for the patient and could only be performed in a very few specialized centers. Thus, with the concern to simplify and to standardize the cell graft production process, we have developed an automated device (StemXpand®) and disposable kits (Stempack®) allowing a nine-day GMP CD34+ stem cell expansion process, starting from a whole blood sample simply withdrawn from the AMI patient after G-CSF mobilization.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
